Relmada Therapeutics, INC.
SEC CIK 1553643 · RLMD · last insider filing 2025-12-16
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Casamento Charles J | Director | filed 2015 - 2025 |
| Traversa Sergio | Director · Chief Executive Officer | filed 2015 - 2025 |
| Glasspool John | Director | filed 2020 - 2025 |
| Shenouda Maged | Director · Chief Financial Officer | filed 2015 - 2025 |
| Kelly Paul Edward | Director · Chief Operating Officer | filed 2015 - 2025 |
| Fedeli Fabiana | Director | filed 2023 - 2025 |
| Schmidt Eric Thomas | Director | filed 2019 - 2023 |
| Agharkar Shreeram | Director | filed 2015 - 2016 |
| Seth Sandesh | Director | filed 2015 - 2015 |
| Yazgi Nabil | Director | filed 2015 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Ence Chuck | Chief Financial Officer | filed 2019 - 2025 |
| O'Gorman Cedric | Chief Medical Officer | filed 2023 - 2023 |
| Wessel Thomas | EVP, Head of R&D | filed 2020 - 2020 |
| Vitolo Ottavio V. | Chief Medical Officer | filed 2018 - 2019 |
| Nolan Lisa | Chief Business Officer | filed 2015 - 2015 |
| Beck Douglas | Chief Financial Officer | filed 2015 - 2015 |
| Salinas Eliseo Oreste | President and CSO | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.